Marksans Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE750C01026
  • NSEID: MARKSANS
  • BSEID: 524404
INR
290.90
-8.25 (-2.76%)
BSENSE

Nov 20

BSE+NSE Vol: 9.82 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
940.17
840.80
856.11
754.43
720.41
619.99
708.46
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
940.17
840.80
856.11
754.43
720.41
619.99
708.46
Raw Material Cost
231.49
220.67
264.97
273.82
227.72
192.69
188.08
Purchase of Finished goods
131.75
138.45
149.81
26.99
106.14
171.55
160.96
(Increase) / Decrease In Stocks
26.83
-15.65
-24.13
15.41
-25.27
-102.43
-23.82
Employee Cost
122.32
114.29
106.76
111.99
103.80
98.39
97.22
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
213.49
170.01
163.28
165.47
163.52
159.67
159.09
Total Expenditure (Excl Depreciation)
725.88
627.77
660.69
593.68
575.91
519.87
581.53
Operating Profit (PBDIT) excl Other Income
214.29
213.03
195.42
160.75
144.50
100.12
126.93
Other Income
18.15
25.40
35.17
20.14
21.57
5.64
15.34
Operating Profit (PBDIT)
232.44
238.43
230.59
180.89
166.07
105.76
142.27
Interest
6.83
7.00
6.31
5.94
5.82
6.07
3.44
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
225.61
231.43
224.28
174.95
160.25
99.69
138.83
Depreciation
32.11
24.86
24.29
24.33
26.92
23.10
22.74
Profit Before Tax
193.50
206.57
200.00
150.62
133.33
76.60
116.09
Tax
49.98
47.16
50.97
36.93
34.20
18.40
25.37
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
143.53
159.41
149.03
113.69
99.14
58.20
90.73
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
143.53
159.41
149.03
113.69
99.14
58.20
90.73
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.21
2.24
0.90
0.49
0.89
-0.12
0.18
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
141.31
157.17
148.13
113.20
98.25
58.32
90.55
Equity Capital
45.32
45.32
45.32
45.32
45.32
45.32
45.32
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.12
3.47
3.27
2.5
2.17
1.29
2.0
Diluted Earnings per share
3.11
3.47
3.27
2.5
2.17
1.29
2.0
Operating Profit Margin (Excl OI)
22.79%
25.34%
22.83%
21.31%
20.06%
16.15%
17.92%
Gross Profit Margin
24.0%
27.52%
26.2%
23.19%
22.24%
16.08%
19.6%
PAT Margin
15.27%
18.96%
17.41%
15.07%
13.76%
9.39%
12.81%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 11.82% vs -1.79% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is -10.09% vs 6.10% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 0.59% vs 9.01% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is -2.43% vs 10.94% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of Marksans Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
940.17
196.70
743.47
377.97%
Other Operating Income
0.00
0.00
0.00
Total Operating income
940.17
196.70
743.47
377.97%
Raw Material Cost
231.49
71.37
160.12
224.35%
Purchase of Finished goods
131.75
0.00
131.75
(Increase) / Decrease In Stocks
26.83
-1.86
28.69
1,542.47%
Employee Cost
122.32
15.61
106.71
683.60%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
213.49
38.34
175.15
456.83%
Total Expenditure (Excl Depreciation)
725.88
123.46
602.42
487.95%
Operating Profit (PBDIT) excl Other Income
214.29
73.24
141.05
192.59%
Other Income
18.15
5.98
12.17
203.51%
Operating Profit (PBDIT)
232.44
79.22
153.22
193.41%
Interest
6.83
2.81
4.02
143.06%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
225.61
76.41
149.20
195.26%
Depreciation
32.11
5.38
26.73
496.84%
Profit Before Tax
193.50
71.03
122.47
172.42%
Tax
49.98
19.22
30.76
160.04%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
143.53
51.81
91.72
177.03%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
143.53
51.81
91.72
177.03%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
2.21
0.36
1.85
513.89%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
141.31
51.45
89.86
174.66%
Equity Capital
45.32
11.29
34.03
301.42%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.12
4.56
-1.44
-31.58%
Diluted Earnings per share
3.11
4.59
-1.48
-32.24%
Operating Profit Margin (Excl OI)
22.79%
37.23%
0.00
-14.44%
Gross Profit Margin
24.00%
38.85%
0.00
-14.85%
PAT Margin
15.27%
26.34%
0.00
-11.07%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 940.17 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 11.82% vs -1.79% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 30.50% vs 12.23% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 141.31 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -10.09% vs 6.10% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 43.83% vs 1.58% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 214.29 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 0.59% vs 9.01% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 48.30% vs -1.57% in Sep 2025

Quarterly - Interest
Interest 6.83 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -2.43% vs 10.94% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 17.35% vs 121.29% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.79%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025